EFDID: 452220EFD: View Filing

Issuer: Areteia Therapeutics, Inc. (0001937542) - D/A

Accession: 0001937542-25-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001937542
  • Entity Name:
    Areteia Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2022)
  • Address:
    101 GLEN LENNOX DR.
    SUITE 300
    CHAPEL HILL, NC 27517
  • Persons:
    Related Persons 11
    Paul Berns
    Director
    Adam Koppel
    Director
    Ian Read
    Director
    Benjamin Gomez
    Director
    Michael E. Bozik
    Director
    Stephen Butts
    Director
    Jorge Bartolome
    Executive Officer, Director
    Elyse Stock
    Director
    Daniel Becker
    Director
    Christopher Courts
    Executive Officer
    Robin Walker
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    02/21/2025
  • First Sale Date:
    06/15/2022
  • Offering Amount:
    $445,000,000
  • Amount Sold:
    $360,000,020
  • Amount Remaining:
    $84,999,980
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, CT, MA, NJ, NY, TX
Inactive:IL
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
COWEN AND COMPANY, LLC 7616 None None All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Areteia Therapeutics, Inc.Jorge BartolomeJorge BartolomeChief Executive Officer2025-02-21
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Feb. 21, 2025 452220: 0001937542-25-000001 Areteia Therapeutics, Inc.
Offer Amount: $445,000,000
Amount Sold: $360,000,020
Remaining: $84,999,980
D/A Feb. 22, 2024 452220: 0001937542-24-000005 Areteia Therapeutics, Inc.
Offer Amount: $445,000,000
Amount Sold: $275,000,000
Remaining: $170,000,000
D Jul. 14, 2022 452220: 0001937542-22-000001 Areteia Therapeutics, Inc.
Offer Amount: $350,000,000
Amount Sold: $175,000,000
Remaining: $175,000,000